Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × Saline Solution × Clear all

Phase

Phase NA 38 Phase 4 22 Phase 3 16 Phase 2 13 Phase 2/3 6 Phase 1 3 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 21 Metformin 13 pembrolizumab 10 Biopsy 10 Radiotherapy 7 Cyclophosphamide 7 Sirolimus 6 Nivolumab 6 Bevacizumab 6 gallium 68 PSMA-11 5 Rituximab 5 Granulocyte Colony-Stimulating Factor 5 Fluorouracil 5 Etoposide 5 Radiosurgery 4 Radiation 4 Methotrexate 4 Fluorodeoxyglucose F18 4 Filgrastim 4 Doxorubicin 4 Cisplatin 4 Aspirin 4 poly ICLC 3 olaparib 3 fluciclovine F-18 3 durvalumab 3 Vitamin D 3 Vincristine 3 Valproic Acid 3 Temozolomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04019834 2022-08-03

RELIEF

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡